|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
These three retailer stocks all are all undervalued and have lots of potential to raise their dividends for years to come.
BioDelivery Sciences International, Inc. (BDSI) announced an agreement with CVS/Caremark to extend access to its pain management product Belbuca and opioid dependence product Bunavail through 2020.
Sheryl Sandberg, Facebook’s acclaimed chief operating officer, reportedly tops Uber’s list to replace lightning-rod chief executive Travis Kalanick, who surrendered his job overnight in the midst of a ...